Cutting-Edge Trial Design & Execution in Obesity
March 4th is World Obesity Day, a unified day of action that calls for a cohesive, cross-sector response to the obesity crisis. Medpace recognizes the urgent need to address this global health crisis and we’re committed to combating obesity through cutting-edge clinical trial design and execution.
With decades of phase I-IV metabolic experience, Medpace is the leading global CRO for obesity clinical studies. Our seasoned medical, operational, and regulatory teams are embedded throughout your project and remain laser-focused on execution – providing unparalleled support for your trial. Extensive team experience, strong relationships with trial sites and key investigators augmented by advanced in-house and external data streams (Intellipace®) enable Medpace to effectively support the planning and successful delivery of rare to multi-trial mega programs.
Learn more about Medpace’s experience in: